Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2005-04-21
2011-11-01
Kim, Alexander (Department: 1656)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C427S002240
Reexamination Certificate
active
08048437
ABSTRACT:
Coatings comprising protein resistant components and therapeutic components on medical devices are disclosed. The coatings act to down-regulate complement activation. Medical devices can be coated with these coatings to prevent side effects and improve patency.
REFERENCES:
patent: 5516703 (1996-05-01), Caldwell et al.
patent: 5853722 (1998-12-01), Rollins et al.
patent: 6497729 (2002-12-01), Moussy et al.
patent: 7459169 (2008-12-01), Nilsson et al.
patent: WO 97/35886 (1997-10-01), None
patent: WO 98/05269 (1998-02-01), None
patent: WO 99/13899 (1999-03-01), None
patent: WO 02/077159 (2002-10-01), None
patent: WO 2004/026328 (2004-04-01), None
patent: WO 2004/037310 (2004-05-01), None
Routh et al. (1997) Journal of Neuroscience Methods, vol. 71, pp. 163-168.
Naylor et al. (1985) Am J. Vet Res., vol. 46, pp. 202-208.
Sauberlich et al. (1999) Clin Oral Implants Res, vol. 10, pp. 379-393.
Green et al. (1998) J. Biomed Mater Res, vol. 42, pp. 165-171.
Mooney et al., Patterning of functional antibodies and other proteins by photolithography of silane monolayers., Proc. Natl. Acad. Sci. USA, 1996, vol. 93, pp. 12287-12291.
Weetall Howard, Preparation of immobilized proteins covalently coupled through silane coupling agents to inorganic supports, Applied Biochemistry and Biotechnology, 1993, vol. 41(3), pp. 157.
Witucki, A Silane Primer: Chemistry and Applictions of Alkoxy Silanes, The Journal of Coating Technology, 1993, vol. 65, pp. 57-60.
Neff et al., A novel method for surface modification to promote cell attachment to hydrophobic substrates, Journal of Biomedical Materials Research Part A, 1998, vol. 40, pp. 511-519.
Cox et al., Surface passivation of microfluidic device to glial cell adhesion: a comparison of hydrophobic and hydrophilic SAM coatings, Biomaterials, 2002, vol. 23, pp. 929-935.
Follstaedt et al., Protein Adhesion on SAM Coated Semiconductor Wafers: Hydrophobic Versus Hydrophilic Surfaces; Sandia Report, Sandia National Laboratories, Dec. 2000, pp. 1-22.
Meth et al., Siloxane-anchored thin films on silicon dioxide-modified stainless steel., Thin Solid Films, 2003, vol. 425, pp. 49-58.
International Search Report issued in PCT/US2005/013417 on Oct. 27, 2005.
J. Andersson, et al., “Binding of a Model Regulator of Complement Activation (RCA) to a Biomaterial Surface: Surface-bound Factor H Inhibits Complement Activation,”Biomaterials22 (2001) 2435-2443.
K. Bergström, et al., “Effects of Branching and Molecular Weight of Surface-Bound Polyethylene oxide) on Protein Rejection,”Biomater. Sci. Polymer Edn., vol. 6, No. 2, pp. 123-132 (1994).
E. Brinkman, et al., “Platelet Deposition Studies on Copolyether Urethanes Modified with Poly (ethylene oxide),”Biomaterials1990, vol. 11, April, pp. 200-205.
N. Desai, et al., “Biological responses to polyethylene oxide modified polyethylene terephthalate surfaces,”J. of Biomedical Materials Research, vol. 25, 829-843 (1991).
Neil Desai, et al., “Solution technique to incorporate polyethylene oxide and other water-soluble polymers into surfaces of polymeric biomaterials,”Biomaterials, 1991, vol. 12, March, pp. 144-153.
Dong Keun Han, et al., “Plasma protein adsorption to sulfonated poly(ethylene oxide)-grafted polyurethane surface,”J. of Biomedical Materials Research, vol. 30, 23-30 (1996).
Gerard R. Llanos, et al., “Does polyethylene oxide possess a low thrombogenicity?”,J. Biomater. Sci. Polymer Edn., vol. 4, No. 4, pp. 381-400 (1993).
Gerard R. Llanos, et al., “Immobilization of poly (ethylene glycol) onto a poly(vinyl alcohol) hydrogel: 2. Evaluation of thrombogenicity,”J. of Biomedical Materials Research, vol. 27, 1383-1391 (1993).
C. Maechling-Strasser, et al., “Preadsorption of polymers on glass and silica to reduce fibrinogen adsorption,”J. of Biomedical Materials Research, vol. 23, 1385-1393 (1989).
E. Österberg, et al., “Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: Comparison to PEG,”J. of Biomedical Materials Research, vol. 29, 741-747 (1995).
D. Paparella, et al., “Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update,”European Journal of Cardio-thoracic Surgery21 (2002) pp. 232-244.
Song Wan, et al., “Inflammatory Responses to Cardiopulmonary Bypass, Mechanisms Involved and Possible Therapeutic Strategies,”Chest1997; 112; 676-692.
Hans Peter Wendel, et al., “Coasting-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation,”European Journal of Cardio-thoracic Surgery16 (1999) 342-350.
Andersson Jonas
Caldwell Karin
Neff Jennifer A.
Nilsson Bo
Nilsson-Ekdahl Kristina
Kim Alexander
Kirton & McConkie
Nagler Richard
Witt Evan R.
LandOfFree
Medical device with surface coating comprising bioactive... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical device with surface coating comprising bioactive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical device with surface coating comprising bioactive... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4277623